Press releaseGlobe Newswire
Globus Medical
GMED · NYSE
$78.96+$3.31 (+4.38%)TodayMarket closed ·
Prev close $75.65
Latest news
- News
Globus Medical Q2 2026 Earnings Call Transcript
- News
Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M Estimate
- Press releaseGlobe Newswire
Globus Medical Reports Second Quarter 2026 Results
- Press releasePRNewswire
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
- Press releaseGlobe Newswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
- Press releasePRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)
- NewsAvi Kapoor
Jim Cramer Flags Industrial Company With 'Almost No Revenue,' Says No To Rocket Companies
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
Globus Medical Q1 Adj. EPS $1.12 Beats $0.92 Estimate, Sales $759.854M Beat $736.999M Estimate
- Press releaseGlobe Newswire
Globus Medical Reports First Quarter 2026 Results
- Press releaseGlobe Newswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
- Press releaseGlobe Newswire
Globus Medical Reports Fourth Quarter and Full Year 2025 Results
- Press releaseGlobe Newswire
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
- NewsAvi Kapoor
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
Market-Moving News for November 7th
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
Globus Medical Reports Third Quarter 2025 Results
- News
Earnings Scheduled For November 6, 2025
- Press releaseGlobe Newswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
- NewsVandana Singh
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
- Press releaseGlobe Newswire
Globus Medical Reports Second Quarter 2025 Results
- Press releaseGlobe Newswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
- News
Price Over Earnings Overview: Globus Medical
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims 0n Behalf of Investors of Globus Medical, Inc. - GMED
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. - GMED
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
- Press releasePRNewswire
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
- Press releaseGlobe Newswire
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
- News
Price Over Earnings Overview: Globus Medical
- NewsVandana Singh
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.